SPECIFIC PHARMA A/S: Financial statements 2017
CVR: 33161395
Source: annual report 2017, Danish Business Authority
01/02/2016 – 31/01/2017
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 142,444,000 and a net result of DKK 26,240,000 compared with DKK 20,193,000 the year before. That is an increase of 1% compared with the year before. The profit margin was 18.4%. Equity in the 2017 report amounted to DKK 74,613,000. The solvency ratio was 74.5%. The company had 8 employees in the financial year.
- Revenue
- DKK 142,444,000
- Gross Profit
- DKK 41,863,000
- Profit/Loss
- DKK 26,240,000
- Equity
- DKK 74,613,000
- Total Assets
- DKK 100,174,000
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 142.4 mio. | 41.9 mio. | 26.2 mio. | 74.6 mio. | 8 |
| 2016 | 141.1 mio. | - | 20.2 mio. | 63.5 mio. | 8 |
| 2015 | 132 mio. | 35.9 mio. | 24.1 mio. | 61.4 mio. | 4 |
| 2014 | 137.8 mio. | 30.3 mio. | 18.7 mio. | 37.3 mio. | - |
| 2013 | 60.1 mio. | 16.8 mio. | 10.6 mio. | 18.6 mio. | - |
Keep an eye on SPECIFIC PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.